Researchers evaluates microsatellite instability-high status, tumor mutation burden and high PD-L1 expression to determine which grade of tumors would benefit from immunotherapy treatment among women ...

Mortality Benefit of a Blood-Based Biomarker Panel for Lung Cancer on the Basis of the Prostate, Lung, Colorectal, and Ovarian Cohort Data of the randomized PORTEC-1 trial (n = 714) comparing pelvic ...

Endometrioid carcinoma (ECa) accounts for ~80% of carcinomas arising in the endometrium. 1, 2 The recognition of its typical morphology and clinical significance are usually straightforward; however, ...

Germline Testing and Somatic Tumor Testing for BRCA1/2 Pathogenic Variants in Ovarian Cancer: What Is the Optimal Sequence of Testing? We identified patients with stage I grade 3 EECs who underwent ...

A recent analysis identified significant disparities in survival outcomes as well as clinical and genetic features between Black and White women with a common subtype of endometrial cancer. In ...

"We’re in an exciting time for clinical research related to endometrial cancer, with a multitude of novel therapies being developed and in clinical trials right now. We’re making significant ...

Panel A shows the age-adjusted incidence of endometrial cancer among Black women and White women on the basis of Surveillance, Epidemiology, and End Results (SEER) data from 1990 through 2017.

Hormonal therapy with an intrauterine device (IUD) led to complete tumor regression in two-thirds of women with early-stage endometrial cancer or precancerous lesions, a randomized pragmatic phase II ...

At the 2026 Society of Gynecologic Oncology Annual Meeting, two major studies offered promising advances for uterine cancer care. The SISTER trial found one‑to‑one peer support significantly improved ...